<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 31-year-old male patient presented with a rapidly growing neck mass with <z:mpath ids='MPATH_458'>normal</z:mpath> thyroid function tests </plain></SENT>
<SENT sid="1" pm="."><plain>Ultrasonography showed thyroidal expansion, a hypoechoic nodule that completely filled the right lobe, and 2 hypoechoic <z:hpo ids='HP_0002716'>lymphadenopathies</z:hpo> in the right jugulodigastric chain </plain></SENT>
<SENT sid="2" pm="."><plain>The patient underwent right total and left subtotal thyroidectomy, following the diagnosis of <z:hpo ids='HP_0005994'>nodular goiter</z:hpo>; however, postoperative histopathological evaluation demonstrated primary Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the thyroid gland </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was staged as stage 1, and R-hyper-CVAD protocol (rituximab, hyperfractionated <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> and <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>) was administered </plain></SENT>
<SENT sid="4" pm="."><plain>The protocol was changed to R-CHOP after 4 cycles due to recurrent grade III/IV cytopenias and febrile <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The PET-CT scans performed after chemotherapy and at the 6-month follow-up were <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>In summary, we reported a case with a diagnosis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, which is a rare type of primary thyroid <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>